<DOC>
	<DOCNO>NCT00127179</DOCNO>
	<brief_summary>The purpose trial determine efficacy safety investigational drug patient benign prostatic hyperplasia .</brief_summary>
	<brief_title>A Study Investigational Study Drug Benign Prostatic Hyperplasia ( 0906-140 )</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<criteria>Patients benign prostatic hyperplasia Patients suspect suffer prostatic cancer</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>